APAC Surgical Simulation Market

APAC Surgical Simulation Market Size (2022 to 2027)

The size of the surgical simulation market in the APAC region is estimated to be growing at a CAGR of 22.11% from 2022 to 2027 and worth USD 168.94 million by 2027 from USD 62.22 million in 2022.

The expansion of the Asia Pacific surgical simulation market is primarily due to an increase in the usage of simulation in healthcare, an increase in mortality due to medical mistakes, and the need to improve patient safety outcomes. In addition, the aging population contributes to a rise in the number of surgical procedures, shaping market growth. The elderly are more susceptible to chronic medical illnesses, such as heart disease, renal disorders, and cancer than younger people, and these conditions frequently necessitate surgical intervention. As a result, a rise in their number will almost certainly result in a significant increase in the demand for surgical simulators.

The increasing number of operations conducted is likely to result in a significant need for simulation products to help avoid or reduce medical errors during surgeries, which is forecasted to drive the expansion of the surgical simulation market in the APAC region. The usage of minimally invasive surgical treatments is steadily increasing as technology advances. For various surgical procedures, less invasive approaches are quickly becoming the norm. Psychomotor skills are required to perform minimally invasive therapy techniques. Simulation is an excellent training and learning method for these skills. As a result, competency-based training and the acceptance of simulation-based education have taken their place. In addition, organic growth techniques such as product launches and developments are being used by vendors, increasing the availability of advanced products in the region. In recent years, 3D printing has gained acceptance in the medical area due to technological improvements. 3D printing technology has evolved from employing 3D models to supplement patient education to patient-specific applications. As a result, the market expansion is aided by the growing popularity of 3D printing in surgical simulation.

On the other hand, the availability of funds in the Asia Pacific region is limited, limiting the market's potential growth. In addition, the high expense of medical simulation is a significant barrier to its widespread usage. The majority of simulators in use today are expensive and require ongoing updates and maintenance. Additionally, operators must be taught how to use software and/or hardware, which takes time and money. Furthermore, simulations require a large amount of maintenance, limiting the surgical simulation market's growth.

This research report on the APAC surgical simulation market has been segmented and sub-segmented the European biomaterials market into the following categories:

By Specialty:

• Products
  • Endoscopic
  • Laparoscopic
  • Cardiac
  • Gynecological
  • Arthroscopic
  • Neurological
• Services
  • Educational
  • Technical

By Application:

• Metal
• Polymer
  • Plastic
  • Others

By End-User:

• Hospitals
• Specialty Centers
• Academic institutes

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Due to the developing medical tourism sector and raising awareness in the region, the APAC market is predicted to grow quickly over the forecast period. Furthermore, as part of their market strategy, prominent companies are investing in the region's unexplored markets, adding to regional market growth. All undergraduate programs in India are required to include simulation-based training. Such government actions will help the regional market thrive. Because of the increased emphasis on medical studies and research, the emerging economies of India and China are likely to have a significant impact on the market. Furthermore, due to an abundance of skilled labor and low manufacturing costs, Asian countries have a high ease of doing business. This is a significant aspect that is expected to boost the Asia-Pacific market.

KEY MARKET PARTICIPANTS:

Royal DSM, Zimmer Biomet Holdings, Inc., Evonik Industries AG, Corbion N.V., Berkeley Advanced Biomaterials, Wright Medical Technology Inc., Covalon Technologies Ltd., Bayer AG, Carpenter Technology Corporation, BASF SE, Invibio Ltd., Inc., CAM Bioceramics BV, and Collagen Matrix, Inc. are some of the noteworthy companies operating in the APAC surgical simulation market profiled in this report.